Artemis Medicare Services Limited (NSE:ARTEMISMED) has scheduled an earnings conference call for August 4, 2026 at 11:00 AM IST to discuss its operational and financial performance for the first quarter of fiscal year 2027. The call will be hosted by Anand Rathi Research and will feature senior management panelists including the Managing Director, Chief Financial Officer, and Head of Investor Relations.
Key Highlights
- Earnings conference call scheduled for Tuesday, August 4, 2026 at 11:00 AM IST to discuss Q1 FY27 results.
- Call will be hosted by Anand Rathi Research and is open to investors and analysts.
- Senior management participants include Dr. Devlina Chakravarty (Managing Director), Mr. Sanjiv Kumar Kothari (Chief Financial Officer), and Mr. Rudra Narayan Acharjee (Head of Investor Relations, M&A and Organization Growth Strategy).
- Multiple dial-in access numbers provided for participants in India and international markets including USA, Hong Kong, UK, and Singapore.
- Company has disclosed Diamond Pass facility and call coordinator contact details for further information and registration.
- Announcement made pursuant to SEBI Listing Obligations and Disclosure Requirements Regulations 2015, Regulation 30.
- Call schedule is subject to change in case of exigencies on the part of analysts, investors, or the company.
About the Company
Artemis Medicare Services Limited is a healthcare services provider listed on both the National Stock Exchange of India (NSE:ARTEMISMED) and the Bombay Stock Exchange (BSE:542919). The company operates in the pharmaceutical and healthcare sector, providing healthcare-related services and solutions. Artemis Medicare is headquartered in India and operates through its clinical and operational infrastructure to serve patients, healthcare providers, and institutional clients across the Indian healthcare ecosystem.
Announcement in Detail
Artemis Medicare Services Limited has formally intimated both the National Stock Exchange of India and the Bombay Stock Exchange of its scheduled earnings conference call on August 4, 2026 at 11:00 AM IST. The intimation was filed on July 29, 2026 in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates that listed companies inform stock exchanges of material corporate events and investor meetings.
The conference call is designed to facilitate detailed discussion of the company's operational and financial performance for the first quarter of fiscal year 2027. The event will be hosted by Anand Rathi Research, an independent financial research firm, and will feature three senior management representatives. Dr. Devlina Chakravarty, the Managing Director, will lead the discussion alongside Mr. Sanjiv Kumar Kothari, the Chief Financial Officer, who will address financial matters, and Mr. Rudra Narayan Acharjee, Head of Investor Relations, M&A and Organization Growth Strategy, who will manage investor queries and provide strategic context.
The company has provided multiple dial-in access numbers to ensure broad participation. Within India, participants can use universal access numbers 022 6280 1386 or 022 7115 8287. International participants have dedicated lines for the USA (+1 866 746 2133), Hong Kong (800 964 448), UK (0808 101 1573), and Singapore (800 101 2045). A Diamond Pass facility is available for streamlined access, and a call coordinator, Himanshu Binani, has been designated to assist participants with registration and technical support.
Impact on Investors
Investors will note that this earnings conference call provides a formal opportunity to interact directly with senior management and obtain detailed insights into the company's operational and financial position for Q1 FY27. The participation of the Managing Director, CFO, and Head of Investor Relations ensures that queries spanning strategic direction, financial performance, capital allocation, and merger and acquisition strategy can be comprehensively addressed. The multi-channel access arrangement, including international dial-in numbers and Diamond Pass facility, indicates the company's commitment to facilitating institutional and retail investor participation across geographies.
The filing shows that the conference call is scheduled ahead of what is typically the formal announcement or filing of Q1 FY27 results, meaning investors should treat this call as a preliminary forum for management commentary rather than an official results disclosure. Shareholders and analysts will observe that the call schedule remains subject to change in the event of unforeseen circumstances, and investors are advised to monitor for any revised notice from the company or the stock exchanges.
Sector / Market Context
Earnings conference calls have become standard practice within the Indian healthcare and pharmaceutical sector, with listed companies using them to provide transparency on operational metrics, clinical outcomes, financial results, and strategic initiatives to the investment community. Regulatory compliance with SEBI Regulation 30 mandates timely disclosure of such investor meetings, ensuring that all market participants receive equal access to management guidance. In the broader healthcare services industry in India, investor engagement through structured conference calls supports price discovery and reduces information asymmetry between company insiders and external stakeholders.